文章摘要
热敏化腧穴埋线与舒利迭对慢性持续性期哮喘的对照观察
A comparative study of thermally sensitized acupoint catgut embedding and Seretide on chronic persistent asthma
投稿时间:2019-05-23  录用日期:2019-07-10
DOI:
中文关键词: 慢性持续期  哮喘  热敏化腧穴  埋线
英文关键词: Chronic persistence  Asthma  Thermosensitized acupoints  Catgut embedding
基金项目:
作者单位E-mail
田春艳 昆明市中医医院 1426245812@qq.com 
管浩 昆明市中医医院  
邓亚萍 昆明市中医医院  
张芳 昆明市中医医院  
李彩莲 昆明市中医医院  
段晓荣 昆明市中医医院 KMDXR@163.com 
摘要点击次数: 22
全文下载次数: 0
中文摘要:
      目的:观察热敏化腧穴埋线与舒利迭对慢性持续期支气管哮喘的疗效差异。方法:将60例符合纳入标准的患者按照随机数字表分为治疗组(热敏化腧穴埋线法,30例)和对照组(舒利迭吸入剂,30例)。热敏化腧穴埋线,每周治疗1次;舒利迭吸入剂,每次1吸,每日两次,治疗3个月。分别在治疗3个月后及治疗后3个月对两组的肺功能(FEV1、PEF)、哮喘控制问卷(Asthma Control Test,ACT)进行分析比较,并进行临床疗效统计。结果:治疗3个月结束时:两组肺功能、ACT评分较前明显提高(均P<0.01),组间比较差异无统计学意义(P>0.05),表明两组疗法的近期疗效基本一致;治疗结束后3个月:热敏化腧穴埋线组肺功能、ACT评分维持治疗结束时水平,而舒利迭组下降明显,且热敏化腧穴埋线组总有效率为80%明显优于舒利迭组的53.4%(P<0.05),表明热敏化腧穴埋线法疗效更持久,远期疗效更佳。结论:热敏化腧穴埋线能有效改善慢性持续期支气管哮喘患者肺功能(FEV1、PEF)及临床症状,其近期疗效与舒利迭基本一致,但远期疗效优于舒利迭。
英文摘要:
      To observe the difference of thermally sensitized acupoint catgut embedding and Seretide in the treatment of chronic persistent bronchial asthma. Methods Sixty patients who met the inclusion criteria were randomly divided into treatment group (thermally sensitized acupoint catgut embedding method, 30 cases) and control group (seretide inhalation, 30 cases). Thermosensitized acupoint catgut embedding once a week; Seretide inhalation once a time, twice a day, for 3 months. The lung function (FEV1, PEF) and asthma control test (ACT) of the two groups were analyzed and compared after 3 months of treatment and 3 months of treatment respectively, and the clinical efficacy was statistically analyzed. Results At the end of 3 months of treatment, the pulmonary function and ACT score of the two groups were significantly improved (all P < 0.01), and there was no significant difference between the two groups (P > 0.05), indicating that the short-term efficacy of the two groups was basically the same; at the end of 3 months, the pulmonary function and ACT score of the thermally sensitized acupoint catgut embedding group maintained the level at the end of treatment, while the Seretide group decreased significantly, and the total of the thermally sensitized acupoint catgut embedding group was the The effective rate of 80% was significantly better than that of the Seretide group 53.4% (P<0.05), indicating that the thermally sensitized acupoint catgut embedding method had a more lasting effect and a better long-term effect.Conclusion Thermosensitized acupoint catgut embedding can effectively improve the lung function (FEV1, PEF) and clinical symptoms of patients with chronic persistent bronchial asthma. Its short-term efficacy is basically the same as that of Seretide, but its long-term efficacy is better than that of Seretide.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭
微信公众号
分享按钮